The Effects of the CF Carrier State on the Kidneys and Pancreas
Recruiting now
Conditions studied: Carrier State, Pancreatic Disease, Kidney Diseases
In brief
The overarching hypothesis is that CF carriers are at increased risk for developing most of the extrapulmonary conditions associated with CF compared to the general population. Specifically, it is hypothesized that this pilot data will detect subclinical evidence of pancreatic and kidney disorders among CF carriers. This will be determined by bringing CF carriers and controls to the CRU for one visit where they will answer survey questions and undergo laboratory testing. Additionally, they will collect urine and stool samples at home that will be sent to outside laboratories for testing.
Key facts
- Study ID
- NCT05474417
- Run by
- Philip Polgreen
- People needed
- 1250
- Starts
- 2021-12-20
- Expected to finish
- 2026-07-01
- Last updated by the study team
- 2026-01-07
Who can join
Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.
You may not qualify if…
- CF patient status
- Unable to speak English
- Currently pregnant
- Unable to provide written informed consent
- Prisoner status
- Currently taking any medications for the treatment of diabetes
Where it is running
- University of Iowa Hospitals and Clinics — Iowa City, Iowa, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.